World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
87
Citations
22238
World Ranking
1224
National Ranking
43

Jan Wilschut publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jan Wilschut sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 324 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jan Wilschut D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jan Wilschut sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 87 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jan Wilschut is affiliated with the University Medical Center Groningen in the Netherlands. Their research primarily focuses on medicine, with a strong emphasis on epidemiology. Other subfields in their work include pulmonary and respiratory medicine, hepatology, health, and genetics.

The scientist's recent publications cover various aspects of viral infections, vaccine development, and health economics. Notable papers include:

  • First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers, 2020, Molecular Therapy
  • Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands, 2020, Value in Health
  • Viral causes of severe acute respiratory infection in hospitalized children and association with outcomes: A two-year prospective surveillance study in Suriname, 2021, PLoS ONE
  • Comparing the impact of high-dose versus standard dose influenza vaccines on hospitalization cost for cardiovascular and respiratory diseases: Economic assessment in the US Veteran population during 5 respiratory seasons using an instrumental variable method, 2020, Vaccine
  • Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands, 2020, The European Journal of Health Economics

Wilschut's frequent co-authors include:

  • Maarten J. Postma
  • Cornelis Boersma
  • Florian Zeevat
  • Job F. H. Eijsink
  • Mohamed N. M. T. Al Khayat

The scientist has published multiple papers in several venues, highlighting the diversity of their research contributions. Frequent publication venues are:

  • Value in Health
  • Infectious Diseases and Therapy
  • Vaccines
  • Molecular Therapy
  • PLoS ONE

Research topics explored by Jan Wilschut include:

  • Respiratory viral infections research
  • Hepatitis B Virus Studies
  • Influenza Virus Research Studies
  • Pneumonia and Respiratory Infections
  • Vaccine Coverage and Hesitancy
  • Hepatitis C virus research
  • Cervical Cancer and HPV Research

This breadth of expertise highlights Wilschut's involvement in both infectious disease research and health economic assessments. Their work spans clinical vaccine trials, epidemiological studies of viral infections, and analyses of vaccination cost-effectiveness, contributing to understanding health outcomes and public health strategy.

Best Publications

  • Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells.

    Hilde M. van der Schaar;Michael J. Rust;Chen Chen;Heidi van der Ende-Metselaar

  • Dengue virus life cycle: viral and host factors modulating infectivity

    Izabela A. Rodenhuis-Zybert;Jan Wilschut;Jolanda M. Smit

  • Flavivirus cell entry and membrane fusion.

    Jolanda M. Smit;Bastiaan Moesker;Izabela Rodenhuis-Zybert;Jan Wilschut

  • The virosome concept for influenza vaccines

    Anke Huckriede;Laura Bungener;Toon Stegmann;Toos Daemen

  • Characterization of the Early Events in Dengue Virus Cell Entry by Biochemical Assays and Single-Virus Tracking

    Hilde M. van der Schaar;Michael J. Rust;Barry-Lee Waarts;Heidi van der Ende-Metselaar

  • Immature Dengue Virus: A Veiled Pathogen?

    Izabela A. Rodenhuis-Zybert;Hilde M. Van Der Schaar;Júlia M. Da Silva Voorham;Heidi Van Der Ende-Metselaar

  • Ca2+-induced fusion of phospholipid vesicles monitored by mixing of aqueous contents

    Jan Wilschut;Demetrios Papahadjopoulos

  • Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine is Primarily Controlled by Toll-like Receptor Signalling

    Felix Geeraedts;Nadege Goutagny;Veit Hornung;Martina Severa

  • Membrane fusion of Semliki Forest virus involves homotrimers of the fusion protein.

    J M Wahlberg;R Bron;J Wilschut;H Garoff

  • Aggregation and fusion of phospholipid vesicles

    Shlomo Nir;J. Bentz;J. Wilschut;Nejat Düzgüneş

  • Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities

    J-P Amorij;Anke Huckriede;Jan Wilschut;Henderik Frijlink

  • Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage

    Jose L. Nieva;Shlomo Nir;Arturo Muga;Felix M. Goni

  • Membrane fusion of Semliki Forest virus in a model system: correlation between fusion kinetics and structural changes in the envelope glycoprotein.

    R Bron;J M Wahlberg;H Garoff;J Wilschut

  • Membrane fusion of Semliki Forest virus requires sphingolipids in the target membrane.

    J L Nieva;R Bron;J Corver;J Wilschut

  • Low-pH-dependent fusion of sindbis virus with receptor-free cholesterol- and sphingolipid-containing liposomes

    Jolanda M. Smit;Robert Bittman;Jan Wilschut

  • FUNCTIONAL RECONSTITUTION OF INFLUENZA-VIRUS ENVELOPES

    T. Stegmann;H. W. M. Morselt;F. P. Booy;J. F. L. Van Breemen

  • Functional importance of dengue virus maturation : infectious properties of immature virions

    Izabela A. Zybert;Heidi van der Ende-Metselaar;Jan Wilschut;Jolanda M. Smit

  • KINETICS OF PH-DEPENDENT FUSION BETWEEN INFLUENZA-VIRUS AND LIPOSOMES

    Toon Stegmann;Dick Hoekstra;G Scherphof;Jan Wilschut

  • Fusion activity of influenza virus. A comparison between biological and artificial target membrane vesicles.

    T Stegmann;D Hoekstra;G Scherphof;J Wilschut

  • Neuroinvasive flavivirus infections

    Gregorius J. Sips;Jan Wilschut;Jolanda M. Smit

  • Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.

    Laura Bungener;Felix Geeraedts;Wouter Ter Veer;Jeroen Medema

  • Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease

    A Holvast;A Huckriede;J Wilschut;G Horst

  • Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system

    Jeroen Corver;Antonio Ortiz;Steven L. Allison;Juliane Schalich

Frequent Co-Authors

Maarten J. Postma
Maarten J. Postma University of Groningen
Anke Huckriede
Anke Huckriede University Medical Center Groningen
Toos Daemen
Toos Daemen University Medical Center Groningen
Jolanda M. Smit
Jolanda M. Smit University Medical Center Groningen
Dick Hoekstra
Dick Hoekstra University Medical Center Groningen
Shlomo Nir
Shlomo Nir Hebrew University of Jerusalem
Nejat Düzgüneş
Nejat Düzgüneş University of the Pacific
Gerrit L. Scherphof
Gerrit L. Scherphof University of Groningen
Eelko Hak
Eelko Hak University of Groningen
Robert Bittman
Robert Bittman City University of New York

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can open multiple career pathways. Many students consider specializations that complement immunology knowledge, such as psychiatric nursing. To find affordable options, check out the cheapest psychiatric nurse practitioner programs, which offer cost-effective routes into advanced nursing roles.

Nurse practitioners often look for accelerated education options to enter the workforce quickly. Programs like the accelerated fnp provide fast-tracked pathways to become family nurse practitioners, combining rigorous training with flexibility.

Career advancement from roles such as family nurse practitioner (FNP) to more specialized acute care positions is another avenue worth exploring. Guidance on how to make this shift effectively can be found in resources like fnp to acnp programs, which detail the necessary steps and certifications.

Understanding salary expectations is crucial when planning your education and career. The dnp salary by state breakdown offers valuable insight into geographic differences in income for Doctor of Nursing Practice professionals, helping students make informed decisions about where to study and work.

Best Scientists Citing Jan Wilschut

Trending Scientists

Recently Published Articles